ONCO Common Stock · Transaction Oct 17, 2025 · Filed Nov 10, 2025 · Amount pending receipt enrichment
NASDAQ NMS - GLOBAL MARKET · ONCO
-3.55% · -$0.0269 · Vol Not reported
Pre-market · updated 05:08:36 ET
Onconetix Inc
Biotechnology
$0.7306
Veridion Score
BETALOW CONF · 6/6 factorsMon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · ONCO
MethodologyONCO
Onconetix Inc
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
AVOID
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
27/ 100
Veridion Score
AVOID · LOW confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ONCO moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Onconetix Inc
PHARMACEUTICAL PREPARATIONSListed since
2022
Employees
2
Country
US
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$0.7575
Last session
Day high
$0.7575
Last session
Day low
$0.7575
Last session
Previous close
$0.7575
52W high
$206.00
-99.65% from high
52W low
$0.7306
0% of range
Market cap
$3M
EPS
$-19.0000
Beta
1.54
Shares out
3.7M
Avg volume
452K
VWAP
$0.7575
Last session
Price history computed in-house
1W
-24.54%
1M
-3.89%
3M
-33.58%
1Y
-99.50%
YTD
-99.06%
SMA 50 $0.9296 · below
SMA 200 $44.09 · below
52W position 0%
ONCO overview
Related filings and maps
Public disclosures
Congress activity in ONCO
Official filing ↗
ONCO Common Stock · Transaction Oct 11, 2023 · Filed Nov 13, 2023 · Amount pending receipt enrichment
ONCO Common Stock · Transaction Aug 24, 2023 · Filed Sep 14, 2023 · Amount pending receipt enrichment
ONCO Common Stock · Transaction Jul 14, 2023 · Filed Aug 16, 2023 · Amount pending receipt enrichment
ONCO Common Stock · Transaction Apr 18, 2023 · Filed May 12, 2023 · Amount pending receipt enrichment
Federal contracts
ONCO contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ONCO in this window.
Lobbying spend
ONCO lobbying filings, year to date.
Registered lobbying filings matched to Onconetix Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ONCO in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ONCO.
Options
Sovereign unlock shows live options positioning for ONCO.